tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY
US Market
Advertisement

Santen Pharmaceutical Co (SNPHY) Drug Pipeline

Compare
6 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Stn1013800 Ophthalmic Solution
Blepharoptosis
Early Phase I
Completed
A Pharmacokinetics (PK) Study in Healthy Adults
Mar 11, 2025
Stn1013800 Ophthalmic Solution, Stn1013800 Ophthalmic Solution Liquid Base, Without Stn1013800
Blepharoptosis
Phase III
Recruiting
A Study in Chinese Patients With Acquired Blepharoptosis
Nov 08, 2024
Latanoprost, De-117B Eye Drops
Ocular Hypertension, Open Angle Glaucoma
Phase III
Recruiting
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Oct 29, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Santen Pharmaceutical Co Ltd (SNPHY) have in its pipeline
      SNPHY is currently developing the following drugs: Stn1013800 Ophthalmic Solution, Stn1013800 Ophthalmic Solution, Stn1013800 Ophthalmic Solution Liquid Base, Without Stn1013800, Latanoprost, De-117B Eye Drops. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis